课题基金 / 基金详情

CANCER TRIALS SUPPORT UNIT IDIQ: TASK ORDER 6A: ELECTRONIC PATIENT-REPORTED OUTCOMES (PROS)

CANCER TRIALS SUPPORT UNIT IDIQ: TASK ORDER 6A: ELECTRONIC PATIENT-REPORTED OUTCOMES (PROS)
癌症试验支持单位 IDIQ:任务令 6A:电子患者报告结果(优点)
批准号:
10703864
负责人:
JAMES WISE
金额:
$82.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2023-07-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objective of the project is to provide operational and development support to the NCI clinical trials program in its effort to identify, deploy, support, and maintain a system for the collection and migration of electronic Patient-Reported Outcomes (ePROs) and other patient-generated health data (PGHD) into the National Cancer Institute (NCI) clinical trial process and systems. The project will be approached in two phases: Phase 1: Requirements and Recommendations, Phase 2: System Configuration and Implementation. The primary objective of Phase 1 will be to identify the requirements for ePRO management, develop a pilot implementation plan, and recommend a software solution that satisfies all stakeholder requirements. The primary objective of Phase 2 will be to build new or modify/configure a commercial off-the-shelf (COTS) product and then maintain, update, and enhance it by following Capability and Maturity Model Integration (CMMI) practices and the Health and Human Services (HHS) Enterprise Performance Life Cycle (EPLC) methodology, working with stakeholders to gather requirements, using a 'Make vs. Buy' decision analysis practices, implementation and configuration, and creating training materials, providing user support as well as a library of licensed PRO questionnaires.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data